(Bloomberg) -- Swiss stocks fell, bringing the
country's key index down from its June 1 record high. Roche
Holding AG slid after the world's biggest maker of cancer
medicines published a study that may prompt some doctors to
prescribe lower doses of a tumor treatment. Synthes Inc. also
declined.
Clariant AG increased after Cash Daily said German rival
Lanxess AG may seek to acquire the chemical maker.
Read more at Bloomberg Stocks News
country's key index down from its June 1 record high. Roche
Holding AG slid after the world's biggest maker of cancer
medicines published a study that may prompt some doctors to
prescribe lower doses of a tumor treatment. Synthes Inc. also
declined.
Clariant AG increased after Cash Daily said German rival
Lanxess AG may seek to acquire the chemical maker.
Read more at Bloomberg Stocks News
No comments:
Post a Comment